New Blood Test Detects Neurogenerative Disease; Offers Hope For Earlier Treatment
Test pinpoints key markers for Alzheimer’s, Parkinson’s, MS, and concussions
Executive Summary
Labcorp has launched a new blood test that has the potential to treat brain diseases and injury more effectively through early detection.
You may also be interested in...
Not Just The Result Of Contact Sports And Combat
A pair of medical experts discuss traumatic brain injuries, their treatments, and some of the long-term complications they can cause, especially when not properly diagnosed and treated.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.